Extensive characterization of COVID-19 convalescent plasma from Bulgarian donors
The total and SARS-CoV-2-specific antibody content in convalescent plasma (CP) samples from Bulgarian donors and their therapeutic potential for COVID-19 patients was subjected to characterization. CPs (n = 90) were obtained after informed consent at National Centre of Transfusion Hematology in Sofi...
Saved in:
| Main Authors: | Vancho Donev, Yana Todorova, Radoslava Emilova, Georgi Nikolov, Maria Nikolova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Biotechnology & Biotechnological Equipment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/13102818.2024.2432986 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Convalescent plasma therapy for COVID-19 – Donor selection strategies and establishment of a plasma bank
by: Mikael Kajova, et al.
Published: (2024-12-01) -
Evaluation of the efficacy of convalescent plasma in moderate to severe COVID-19 during 2020-2021: a retrospective observational study
by: Sunny Kumar, et al.
Published: (2024-12-01) -
Convalescent plasma therapy in severe coronavirus disease-2019: A narrative review
by: Rasmi Ranjan Sahoo, et al.
Published: (2020-01-01) -
Evaluation of the Effectiveness of Convalescent Plasma Therapy in Severe and Critical COVID-19
by: Özhan Özcan, et al.
Published: (2024-12-01) -
Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or neuromyelitis Optica spectrum disorder with Covid-19: A multicenter retrospective study
by: Tanguy Dequidt, et al.
Published: (2025-02-01)